The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
Open Access
- 1 April 1984
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 73 (4) , 1156-1166
- https://doi.org/10.1172/jci111301
Abstract
The National Cooperative Gallstone Study was a double-masked trial conducted to determine the efficacy and safety of chenodeoxycholic acid (chenodiol) for dissolution of cholesterol gallstones. Patients with radiolucent gallstones were randomly allocated to either a high dose (750 mg/d, n = 305) or low dose (375 mg/d, n = 306) of chenodiol or placebo (n = 305) administered for 2 yr. Specimens of gallbladder bile were obtained for biliary lipid analysis on 50% of all white obtained for biliary lipid analysis on 50% of all white patients at base line and after 3-mo therapy, on 45% at 12 mo, and on 36% at 24 mo. Among these specimens, 20% were inadequate for analysis. For analysis of data, available values during therapy were averaged up to time of dissolution, study exit, or study termination. In the high-dose group, percent chenodiol (molar percent of all bile acids) increased markedly and remained high during the 2 yr of follow-up. Also, molar percent cholesterol decreased significantly and remained low during the 2 yr of follow-up. In the low-dose group, percent chenodiol increased and remained significantly increased. Percent cholesterol saturation decreased at 3 mo, but at 24 mo it was not different from that in the placebo group, suggesting a physiological adaptation to the low dose by 2 yr. 79% of patients on high dose had greater than 70% chenodiol. Among these, half showed unsaturated bile (less than 100% cholesterol saturation) while the remainder were supersaturated; in the former group with unsaturated bile, 23% had complete dissolution and 51% had partial (greater than 50% reduction in stone size) or complete dissolution. In contrast, those with over 70% chenodiol and supersaturated bile had only 5% complete dissolution. Thus, development of unsaturated bile was a major factor associated with gallstone dissolution. The data also indicate that values for percent cholesterol saturation were a better predictor of gallstone dissolution than molar percent chenodiol, although a high percent chenodiol usually was required to obtain unsaturation.This publication has 31 references indexed in Scilit:
- Effects of obesity and caloric intake on biliary lipid metabolism in man.Journal of Clinical Investigation, 1975
- Sulfated and Nonsulfated Bile Acids in Urine, Serum, and Bile of Patients with Hepatobiliary DiseasesGastroenterology, 1975
- Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.1973
- Efficacy and Specificity of Chenodeoxycholic Acid Therapy for Dissolving GallstonesNew England Journal of Medicine, 1973
- GALLSTONE DISSOLUTION IN MAN USING CHENODEOXYCHOLIC ACIDThe Lancet, 1972
- Mechanisms of Lithogenic Bile Formation in American Indian Women with Cholesterol GallstonesJournal of Clinical Investigation, 1972
- Dissolution of Cholesterol Gallstones by Chenodeoxycholic AcidNew England Journal of Medicine, 1972
- Induced Alterations in Composition of Bile of Persons Having CholelithiasisGastroenterology, 1971
- The solubility of cholesterol in aqueous solutions of bile salts and lecithinZeitschrift Fur Ernahrungswissenschaft, 1971
- Analysis of Categorical Data by Linear ModelsPublished by JSTOR ,1969